BOLT
Bolt Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.56
+6.43%Leverage
- Debt / equity
- 1.71x
- Net debt / equity
- 0.69x
- Debt / assets
- 0.54x
- Debt / EBITDA
- -0.78x
- Net debt / EBITDA
- -0.32x
Liquidity & coverage
- Current ratio
- 2.61x
- Quick ratio
- 2.61x
- Cash ratio
- 2.24x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $12.7M
Cash & dividend
- FCF / debt
- -1.46x
- Cash flow / debt
- -1.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -15.6%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026